Genetically transforming human mesenchymal stem cells to sarcomas: Changes in cellular phenotype and multilineage differentiation potential

Cancer

Volumn 115, Issue 20, 2009, Pages 4795-4806

  Li, Nan ^a   Yang, Rui ^a   Zhang, Wendong ^a   Dorfman, Howard ^a   Rao, Pulivarthi ^b   Gorlick, Richard ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Human mesenchymal stem cell; Multilineage differentiation potential; Osteosarcoma; Tumorigenesis

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; VIRUS T ANTIGEN;

ARTICLE; CARCINOGENESIS; CASE REPORT; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOTILITY; CELL TRANSFORMATION; CHILD; CONTROLLED STUDY; GENE EXPRESSION; GENETIC LINKAGE; GENETIC TRANSFORMATION; GENOTYPE; HUMAN; HUMAN CELL; KARYOTYPE; LENTIVIRINAE; MALE; MESENCHYMAL STEM CELL; ONCOGENE H RAS; OSTEOSARCOMA; OSTEOSARCOMA CELL; PHENOTYPE; PRIORITY JOURNAL; RETROVIRUS; SCHOOL CHILD; SIMIAN VIRUS 40;

CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL LINEAGE; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CHILD; GENE EXPRESSION PROFILING; HUMANS; MALE; MESENCHYMAL STEM CELLS; OSTEOSARCOMA; PHENOTYPE; PLURIPOTENT STEM CELLS; SARCOMA; TRANSFECTION;

EID: 70350088421     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24519     Document Type: Article

References (31)

1. Meyers PA, Gorlick R. Osteosarcoma. Pediatr Clin North Am. 1997;44:973-989.
2. Kansara M, Thomas DM. Molecular pathogenesis of osteosarcoma. DNA Cell Biol. 2007;26:1-18.
3. Hulse N, Paul AS. Soft tissue osteosarcoma: a case report. Acta Orthop Belg. 2006;72:783-785. (Pubitemid 46048250)
4. Bahrami A, Resetkova E, Ro JY, et al. Primary osteosarcoma of the breast: report of 2 cases. Arch Pathol Lab Med. 2007;131:792-795. (Pubitemid 46726144)
5. Vaananen HK. Mesenchymal stem cells. Ann Med. 2005; 37:469-479.
6. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147. (Pubitemid 29282067)
7. Miura M, Miura Y, Padilla-Nash HM, et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells. 2006;24:1095-1103. (Pubitemid 44464742)
8. Tolar J, Nauta AJ, Osborn MJ, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells. 2007; 25:371-379. (Pubitemid 46232791)
9. Rubio D, Garcia-Castro J, Martin MC, et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005; 65:3035-3309 (Pubitemid 40524580)
10. Serakinci N, Guldberg P, Burns JS, et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene. 2004;23:5095-5508 (Pubitemid 38938744)
11. Tirode F, Laud-Duval K, Prieur A, et al. Mesenchymal stem cell features of Ewing tumors. Cancer Cell. 2007; 11:421-429. (Pubitemid 46680428)
12. Hahn WC, Counter CM, Lundberg AS, et al. Creation of human tumour cells with defined genetic elements. Nature. 1999;400:464-468.
13. Rich JN, Guo C, McLendon RE, et al. A genetically tractable model of human glioma formation. Cancer Res. 2001;61:3556-3560. (Pubitemid 32694959)
14. Sonoda Y, Ozawa T, Hirose Y, et al. Formation of intracranial tumors by genetically modified human astrocytes defines 4 pathways critical in the development of human anaplastic astrocytoma. Cancer Res. 2001;61:4956-4960. (Pubitemid 32681517)
15. Liu J, Yang G, Thompson-Lanza JA, et al. A genetically defined model for human ovarian cancer. Cancer Res. 2004; 64:1655-1663. (Pubitemid 38428686)
16. Linardic CM, Downie DL, Qualman S, et al. Genetic modeling of human rhabdomyosarcoma. Cancer Res. 2005; 65:4490-5445
17. Ulaner GA, Huang HY, Otero J, et al. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res. 2003;63: 1759-1763. (Pubitemid 36469314)
18. Terasaki T, Kyo S, Takakura M, et al. Analysis of telomerase activity and telomere length in bone and soft tissue tumors. Oncol Rep. 2004;11:1307-1311.
19. Overholtzer M, Rao PH, Favis R, et al. The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci U S A. 2003;100:11547-11552. (Pubitemid 37205973)
20. Mendoza SM, Konishi T, Miller CW. Integration of SV40 in human osteosarcoma DNA. Oncogene. 1998;17:2457-2462. (Pubitemid 28544715)
21. Antillon-Klussmann F, Garcia-Delgado M, Villa-Elizaga I, et al. Mutational activation of ras genes is absent in pediatric osteosarcoma. Cancer Genet Cytogenet. 1995;79:49-53.
22. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258:818-821.
23. Yang R, Hoang BH, Kubo T, et al. Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma. Int J Cancer. 2007;121:943-954.
24. Shima Y, Okamoto T, Aoyama T, et al. In vitro transformation of mesenchymal stem cells by oncogenic HrasVal12. Biochem Biophys Res Commun. 2007;353:60-66.
25. Ince TA, Richardson AL, Bell GW, et al. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell. 2007;12:160-170.
26. Guo F, Gao Y, Wang L, et al. p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities. J Biol Chem. 2003;278:14414-14419. (Pubitemid 36799994)
27. Kim MS, Lee EJ, Kim HR, et al. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 2003;63:5454-5461.
28. Xia M, Land H. Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat Struct Mol Biol. 2007;14:215-223. (Pubitemid 46355577)
29. Berman SD, Calo E, Landman AS, et al. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci U S A. 2008;105: 11851-11856.
30. Dass CR, Ek ET, Choong PF. Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing. J Cancer Res. Clin Oncol. 2007;133:193-198.
31. Walkley CR, Qudsi R, Sankaran VG, et al. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev. 2008;22:1662-1676. (Pubitemid 351846845)